|
1
|
Olden KW and Schuster MM: Irritable bowel
syndrome. Sleisenger and Fordtran's Gastrointestinal and Liver
Disease. Feldman M, Scharschmidt BF and Sleisenger MH: W.B.
Saunders Co; Philadelphia: pp. 1536–1547. 1998
|
|
2
|
Kanazawa M, Hongo M and Fukudo S: Visceral
hypersensitivity in irritable bowel syndrome. J Gastroenterol
Hepatol. 26(Suppl 3): 119–121. 2011. View Article : Google Scholar
|
|
3
|
Zhao Y, Ke M, Wang Z, Wei J, Zhu L, Sun X
and Zhang J: Pathophysiplogical and psychosocial study in patients
with functional vomiting. J Neurogastroenterol Motil. 16:274–280.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zung WW: A self-rating depression scale.
Arch Gen Psychiatry. 12:63–70. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zung WW: A rating instrument for anxiety
disorders. Psychosomatics. 12:371–379. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fishbain D: Evidence-based data on pain
relief with antidepressants. Ann Med. 32:305–316. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Caso JR, Leza JC and Menchén L: The
effects of physical and psychological stress on the
gastro-intestinal tract: lessons from animal models. Curr Mol Med.
8:299–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Crowell MD, Harris L, Jones MP and Chang
L: New insights into the pathophysiology of irritable bowel
syndrome: implications for future treatments. Curr Gastroenterol
Rep. 7:272–279. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Binimelis J, Webb SM and Monés J:
Somatostatin and irritable bowel syndrome. Lancet. 2:15331987.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wouters MM and Boeckxstaens GE:
Neuroimmune mechanisms in functional bowel disorders. Neth J Med.
69:55–61. 2011.PubMed/NCBI
|
|
12
|
Spiller R: Recent advances in
understanding the role of serotonin in gastrointestinal motility in
functional bowel disorders: alterations in 5-HT signalling and
metabolism in human disease. Neurogastroenterol Motil. 19(Suppl 2):
25–31. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Talley NJ, Kellow JE, Boyce P, Tennant C,
Huskic S and Jones M: Antidepressant therapy (imipramine and
citalopram) for irritable bowel syndrome: a double-blind,
randomized, placebo-controlled trial. Dig Dis Sci. 53:108–115.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Camilleri M and Fealy RO: Idiopathic
autonomic denervation in eight patients presenting with functional
gastrointestinal disease: A causal association? Dig Dis Sci.
35:609–616. 2008. View Article : Google Scholar
|
|
15
|
Smart HL and Atkinson M: Abnormal vagal
function in irritable bowel syndrome. Lancet. 2:475–478. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ringel Y, Sperber AD and Drossman DA:
Irritable bowel syndrome. Annu Rev Med. 52:319–338. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simrén M, Abrahamsson H and Björnsson ES:
An exaggerated sensory component of the gastrocolonic response in
patients with irritable bowel syndrome. Gut. 48:20–27. 2001.
|
|
18
|
Liebregts T, Adam B, Bredack C, et al:
Immune activation in patients with irritable bowel syndrome.
Gastroenterology. 132:913–920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Drossman DA: Brain imaging and its
implications for studying centrally targeted treatments in
irritable bowel syndrome: a primer for gastroenterologists. Gut.
54:569–573. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gonçalves L, Almeida A and Pertovaara A:
Pronociceptive changes in response properties of rostroventromedial
medullary neurons in a rat model of peripheral neuropathy. Eur J
Neurosci. 26:2188–2195. 2007.PubMed/NCBI
|
|
21
|
Spence MJ and Moss-Morris R: The cognitive
behavioural model of irritable bowel syndrome: a prospective
investigation of patients with gastroenteritis. Gut. 56:1066–1071.
2007. View Article : Google Scholar
|
|
22
|
Ladep NG, Obindo TJ, Audu MD, Okeke EN and
Malu AO: Depression in patients with irritable bowel syndrome in
Jos, Nigeria. World J Gastroenterol. 12:7844–7847. 2006.PubMed/NCBI
|
|
23
|
Gonsalkorale WM, Perrey C, Pravica V,
Whorwell PJ and Hutchinson IV: Interleukin 10 genotypes in
irritable bowel syndrome: evidence for an inflammatory component?
Gut. 52:91–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Holsboer F: The corticosteroid receptor
hypothesis of depression. Neuropsychopharmacology. 23:477–501.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kronfol Z and Remick DG: Cytokines and the
brain: implications for clinical psychiatry. Am J Psychiatry.
157:683–694. 2000. View Article : Google Scholar : PubMed/NCBI
|
